This thesis presents the first work, to our knowledge, to evaluate the potential of Optical Coherence Tomography (OCT) as an intravascular imaging modality to characterize and guide interventions on chronic total occlusions (CTOs) in arteries. An ex vivo imaging study using OCT is presented that characterizes various pathologies associated with peripheral CTOs and illustrates the ability to differentiate between the vessel wall and the occluded lumen. We also found that, while OCT could image approximately 1mm through tissue, it was effective for imaging deeper through clarified microchannels seen within the occluded lumen. While others had reported observing such microchannels within the lumen before, little was known about the global architecture of these channels. This motivated a study of the global morphology of microchannels in occlusions using micro computed tomography (microCT). In this microCT study, we found that microchannels within the occluded lumen of the artery appeared to be continuous over several millimeters. However, these channels also exited the artery frequently, suggesting the need for some form of imaging guidance. As a potential intravascular imaging set-up, a forward-viewing OCT catheter was built. This catheter uses a novel scanning mechanism that combines high voltage and a dissipative polymer to achieve fast compact actuation. Doppler OCT results are presented using this catheter to image flow in the forward direction. Doppler OCT imaging of microchannels in vivo is also shown in a surgically exposed occluded artery in situ.

This thesis presents the first work, to our knowledge, to evaluate the potential of Optical Coherence Tomography (OCT) as an intravascular imaging modality to characterize and guide interventions on chronic total occlusions (CTOs) in arteries. An ex vivo imaging study using OCT is presented that characterizes various pathologies associated with peripheral CTOs and illustrates the ability to differentiate between the vessel wall and the occluded lumen. We also found that, while OCT could image approximately 1mm through tissue, it was effective for imaging deeper through clarified microchannels seen within the occluded lumen. While others had reported observing such microchannels within the lumen before, little was known about the global architecture of these channels. This motivated a study of the global morphology of microchannels in occlusions using micro computed tomography (microCT). In this microCT study, we found that microchannels within the occluded lumen of the artery appeared to be continuous over several millimeters. However, these channels also exited the artery frequently, suggesting the need for some form of imaging guidance. As a potential intravascular imaging set-up, a forward-viewing OCT catheter was built. This catheter uses a novel scanning mechanism that combines high voltage and a dissipative polymer to achieve fast compact actuation. Doppler OCT results are presented using this catheter to image flow in the forward direction. Doppler OCT imaging of microchannels in vivo is also shown in a surgically exposed occluded artery in situ.

abstract: This thesis investigated two different thermal flow sensors for intravascular shear stress analysis. They were based on heat transfer principle, which heat convection from the resistively heated element to the flowing fluid was measured as a function of the changes in voltage. For both sensors, the resistively heated elements were made of Ti/Pt strips with the thickness 0.12 µm and 0.02 µm. The resistance of the sensing element was measured at approximately 1.6-1.7 kohms;. A linear relation between the resistance and temperature was established over the temperature ranging from 22 degree Celsius to 80 degree Celsius and the temperature coefficient of resistance (TCR) was at approximately 0.12 %/degree Celsius. The first thermal flow sensor was one-dimensional (1-D) flexible shear stress sensor. The structure was sensing element sandwiched by a biocompatible polymer "poly-para-xylylene", also known as Parylene, which provided both insulation of electrodes and flexibility of the sensors. A constant-temperature (CT) circuit was designed as the read out circuit based on 0.6 µm CMOS (Complementary metal-oxide-semiconductor) process. The 1-D shear stress sensor suffered from a large measurement error. Because when the sensor was inserted into blood vessels, it was impossible to mount the sensor to the wall as calibrated in micro fluidic channels. According to the previous simulation work, the shear stress was varying and the sensor itself changed the shear stress distribution. We proposed a three-dimensional (3-D) thermal flow sensor, with three-axis of sensing elements integrated in one sensor. It was in the similar shape as a hexagonal prism with diagonal of 1000 µm. On the top of the sensor, there were five bond pads for external wires over 500 µm thick silicon substrate. In each nonadjacent side surface, there was a bended parylene branch with one sensing element. Based on the unique 3-D structure, the sensor was able to obtain data along three axes. With computational fluid dynamics (CFD) model, it is possible to locate the sensor in the blood vessels and give us a better understanding of shear stress distribution in the presence of time-varying component of blood flow and realize more accurate assessment of intravascular convective heat transfer. / Dissertation/Thesis / M.S. Electrical Engineering 2011

La revisión crítica titulada Eficacia de los dispositivos de fijación: esparadrapo y apósito transparente del catéter venoso periférico (CVP) en el manejo del paciente de emergencia, tuvo como objetivo identificar qué dispositivo es eficaz en el aseguramiento del CVP, estos dispositivos utilizados frecuentemente en los servicios de emergencias. La elección del dispositivo más idóneo para la fijación será clave para un cuidado adecuado y así evitar complicaciones, ello podría basarse en la adherencia, la resistencia, la visualización del punto de punción y el tipo de paciente; este trabajo académico busca encontrar qué dispositivo es más efectivo y adecuado para la diminución de las complicaciones. La metodología utilizada fue enfermería basada en evidencia, con la interrogante ¿qué dispositivo: esparadrapo o apósito transparente tiene mayor eficacia en la fijación del CVP en el manejo del paciente de emergencia? Se realizó búsqueda en Cochrane library, Pub Med, SCielo; seleccionándose 9 investigaciones, de las cuales 5 pasaron el filtro de Gálvez Toro. Eligiéndose el artículo denominado: Dispositivos de fijación para asegurar catéteres venosos periféricos para prevenir complicaciones – 2015 por su nivel de evidencia y grado de recomendación: 1+/B utilizando la lista de chequeo Caspe; concluyendo que en la actualidad no se ha encontrado evidencia de una diferencia de mayor eficacia de los dispositivos de fijación para asegurar un CVP. Este procedimiento debería realizarse en base a protocolos que permitan actuar de una manera uniforme a todos los profesionales enfermeros, utilizando el dispositivo de fijación que brinde más beneficios, animando a nuevas investigaciones de alta calidad en esta área.

Indiana University-Purdue University Indianapolis (IUPUI) / Metabolic syndrome (MetS) affects 1/3 of all Americans and is the clustering of three or more of the following cardiometabolic risk factors: obesity, hypertension, dyslipidemia, glucose intolerance, and insulin resistance. MetS drastically increases the incidence of coronary artery disease (CAD), which is the leading cause of mortality globally. A cornerstone of CAD is arterial remodeling associated with coronary smooth muscle (CSM) cytodifferentiation from a contractile phenotype to proliferative and osteogenic phenotypes. This cytodifferentiation is tightly coupled to changes in intracellular Ca2+ handling that regulate several key cellular functions, including contraction, transcription, proliferation, and migration. Our group has recently elucidated the time course of Ca2+ dysregulation during MetS-induced CAD development. Ca2+ transport mechanisms, including voltage-gated calcium channels, sarcoplasmic reticulum (SR) Ca2+ store, and sarco-endoplasmic reticulum Ca2+ ATPase (SERCA), are enhanced in early, mild disease and diminished in late, severe disease in the Ossabaw miniature swine. Using this well-characterized large animal model, I tested the hypothesis that this Ca2+ dysregulation pattern occurs in multiple etiologies of CAD, including diabetes and aging. The fluorescent intracellular Ca2+ ([Ca2+]i) indicator fura-2 was utilized to measure [Ca2+]i handling in CSM from lean and diseased swine. I found that [Ca2+]i handling is enhanced in mild disease with minimal CSM phenotypic switching and diminished in severe disease with greater phenotypic switching, regardless of CAD etiology. We are confident of the translatability of this research, as the Ca2+ influx, SR Ca2+ store, and SERCA functional changes in CSM of humans with CAD are similar to those found in Ossabaw swine with MetS. Single-cell RNA sequencing revealed that CSM cells from an organ culture model of CAD exhibited many different phenotypes, indicating that phenotypic modulation is not a discreet event, but a continuum. Transcriptomic analysis revealed differential expression of many genes that are involved in the osteogenic signaling pathway and in cellular inflammatory responses across phenotypes. These genes may be another regulatory mechanism common to the different CAD etiologies. This study is the first to show that CSM Ca2+ dysregulation is common among different CAD etiologies in a clinically relevant animal model.

No description available.

Coronary artery disease affects millions of people and the ability to detect and treat the disease is advancing at a rapid rate. As a result, the development of intravascular technologies is the focus of many medical device manufacturers. Specifically, coronary stent implantation is being performed in an increasing number of patients and a number of new stent designs have been introduced to the market, resulting in the need for improved preclinical testing methods. An in vitro tissue engineered “blood vessel mimic” (BVM) system has previously been established and its feasibility for the initial testing of newly emerging intravascular technology has been demonstrated. There are limitations that exist with this original design, however, and the focus of this thesis was to both improve and expand upon the original model. Therefore, research was conducted based on two specific aims. The first aim was to develop a more ideal BVM system to accommodate a wider range of stent lengths and diameters, while allowing for easy graft insertion and seal-ability. The second aim was to develop next generation BVM systems,focused on future needs and technology, such as long, angulated and bifurcated geometries. The work described in this thesis demonstrates that a BVM chamber can be created which has the advantages of easy graft insertion and seal-ability, as well as the ability to accommodate varying sizes of vessel scaffolds, all while maintaining the needs of a tissue engineering bioreactor system. The next generation BVM systems presented demonstrate that the BVM concept can be expanded to meet the needs of long, angulated and bifurcated geometries. Overall, the work in this thesis describes the design and optimization of an in vitro blood vessel mimic bioreactor system for the evaluation of intravascular devices, specifically coronary stents, in simple and complex vessel geometries.

Pacientes envenenados pela serpente Bothrops jararaca manifestam uma tendência hemorrágica em que a plaquetopenia é um achado consistente. Manifestações clínicas sistêmicas, como sangramento de mucosas e microangiopatia trombótica em alguns pacientes, apresentam similaridades com sinais clínicos de doença de von Willebrand e púrpura trombocitopênica trombótica. Algumas proteínas do veneno - como a botrocetina (uma proteína relacionada às lectinas do tipo C) e as metaloproteinases do veneno (SVMP) - interferem direta ou indiretamente na interação entre plaquetas e o fator de von Willebrand (vWF) in vitro e in vivo. E dessa forma, podem contribuir para os sangramentos induzidos pelo envenenamento devido à importância que o vWF tem para a hemostasia primária. Pensando em compreender a participação do vWF do organismo e a botrocetina e as SVMP do veneno bruto de B. jararaca (BjV) na plaquetopenia induzida pelo envenenamento, utilizamos dois modelos experimentais: ratos Wistar heterogênicos e camundongos nocautes do gene Vwf (Vwf-/-). No modelo em ratos, o BjV foi pré-incubado com salina (controle positivo), um inibidor de metaloproteinases (Na2-EDTA), anticorpos policlonais anti-botrocetina, glicerol (veículo dos anticorpos), ou a combinação do Na2-EDTA e anticorpos anti-botrocetina; o grupo controle negativo foi injetado somente com salina. Após a administração subcutânea (s.c.) dos venenos tratados (1,6 mg/kg), amostras de sangue foram coletadas após 3, 6 ou 24 h, e analisaram-se a contagem de plaquetas, quantificação antigênica (vWF:Ag) e da atividade de ligação do vWF ao colágeno (vWF:CB), a atividade de ADAMTS13, a distribuição multimérica de vWF, e a atividade coagulante de fator VIII (FVIII). Para explorar a participação do vWF na plaquetopenia, camundongos nocautes de vWF (Vwf-/-) e camundongos controles (C57BL/6) foram injetados s.c. com BjV incubado com salina (grupo positivo do envenenamento) ou apenas salina (grupo controle negativo). As injeções dos tratamentos, bem como os períodos analisados foram idênticos aos dos ratos. Em nossos resultados, todos os ratos injetados com algum tratamento de BjV, inclusive nos animais que receberam veneno pré-tratado com anticorpo anti-botrocetina e/ou Na2-EDTA, apresentaram plaquetopenia, com maior intensidade em 6 h. Na avaliação do vWF foi encontrada uma grande variação individual nos grupos de tratamentos, porém ainda assim houve uma tendência a redução nos níveis de vWF:Ag em 3 e 6 h nos ratos que receberam BjV sem inibidores. A administração de BjV tratado somente com anticorpo anti-botrocetina promoveu uma maior redução nos níveis de vWF:Ag em 3 h, com retorno aos níveis semelhantes aos de controle negativo em 6 h e 24 h. A inibição sozinha das metaloproteinases não promoveu efeito importante, porém em 6 h, potencializou a ação do anticorpo anti-botrocetina na inibição conjunta do decréscimo de vWF:Ag e vWF:CB. A análise dos multímeros do vWF mostrou perfis bastante variáveis individualmente, porém os multímeros de alto peso molecular e intermediário tenderam a diminuir e os de baixo peso a aumentar nos animais que receberam algum tratamento com BjV, especialmente em 24 h. Na dosagem de FVIII, houve redução em 3 e 6 h em todos os ratos que receberam qualquer tratamento de BjV, sem grandes variações entre esses grupos. A atividade de ADAMTS13 apresentou uma redução dos valores em 3 e 6 h, que foi revertida pela inibição das metaloproteinases do veneno. Já nos camundongos, a plaquetopenia esteve presente em todos os animais nocautes e controles que receberam BjV, mostrando ser independente da presença de vWF. Nos camundongos controles (C57BL/6), não houve alterações evidentes em vWF:Ag durante o envenenamento, porém em 3 h houve uma tendência a sua diminuição. Em conjunto, nossos resultados mostram que a presença da botrocetina no veneno bruto não afeta a plaquetopenia desencadeada pelo envenenamento, porém influencia o vWF plasmático quantitativa e funcionalmente. As metaloproteinases do veneno têm forte efeito sobre a enzima fisiológica reguladora da atividade biológica do vWF, a ADAMTS13, que indiretamente pode afetar os níveis de vWF. Ademais, a intensidade da plaquetopenia durante o envenenamento de B. jararaca não depende da presença de vWF, e tendo em conta o caráter multifatorial do consumo plaquetário durante o envenenamento, sugerimos que outros mecanismos possam ser responsáveis pela plaquetopenia induzida pelo BjV. Com isso, concluímos que o consumo de vWF no envenenamento por B. jararaca é um fator contribuinte, porém não determinante, para as alterações da contagem plaquetária / Patients bitten by Bothrops snakes manifest a bleeding tendency in which thrombocytopenia is consistently observed. Systemic clinical manifestations, such as mucous bleeding and thrombotic microangiopathy in some patients, share similarities with symptoms of von Willebrand disease and thrombotic thrombocytopenic purpura. Some venom proteins - e.g. botrocetin (a C-type lectin-related protein) and snake venom metalloproteinases (SVMP) - disturbs, direct or indirectly, the interaction between platelets and von Willebrand factor (vWF) in vitro and in vivo, and may contribute thereby to snakebite-induced bleedings, once vWF is required for primary hemostasis. To better understand the relation between plasma vWF, and botrocetin and SVMPs from B. jararaca crude venom (BjV) in the thrombocytopenia induced by envenomation, we used two experimental models: Wistar heterogenic rats and vWF knockout mice (Vwf-/-). In the rat model, BjV was pre-incubated with saline (positive control), metalloproteinase inhibitor (Na2-EDTA), polyclonal anti-botrocetin antibodies, glycerol (antibody vehicle), or the combination of Na2-EDTA and anti-botrocetin antibodies; the negative control group was injected with saline only. After subcutaneous injection (s.c.) of treated venom (1.6 mg/kg), blood samples were collected after 3, 6 or 24 h, and platelet count, vWF antigen (vWF:Ag) and collagenbinding activity (vWF:CB), ADAMTS13 activity, vWF multimer distribution, and factor VIII (FVIII) coagulant activity were analyzed. To investigate the participation of vWF in thrombocytopenia, vWF knockout mice (Vwf-/-) and control mice (C57BL/6) were injected s.c. with saline only (negative control group) or BjV pre-incubated with saline (positive control group). The same protocols used for rats were accomplished in mice. Our results showed that all rats injected with any BjV treatment, including animals which received anti-botrocetin antibodies and/or Na2-EDTA-treated BjV, showed thrombocytopenia, with the nadir at 6h. vWF analysis exhibited a large individual variation among treatment groups, but there was a tendency to reduce vWF:Ag levels at 3 and 6 h in rats that received BjV pre-incubated with saline (without any inhibitor). Administration of BjV pre-incubated only with anti-botrocetin antibodies evoked a large reduction in vWF:Ag levels at 3 h, which returned to levels similar to those of the negative control group at 6 and 24 h. SVMP inhibition alone did not induce an important effect, but potentialized the activity of anti-botrocetin antibodies to inhibit the fall in both vWF:Ag and vWF:CB levels at 6 h. VWF multimer analysis had a large individual profile variation, although animals that received any BjV treatment tended to decrease the high and intermediate molecular weight multimers and to increase the low ones, especially at 24 h. FVIII showed diminished levels in all rats that received any BjV treatment at 3 and 6 h, without important variations among groups. Decreased levels of ADAMTS13 activity were noticed at 3 and 6 h, which were reverted by SVMP inhibition. In mice, thrombocytopenia was present in all control and knockout mice that received BjV, demonstrating independence of vWF presence. In control mice (C57BL/6), there were no relevant alterations in vWF:Ag during envenomation, although at 3 h there was a tendency to decrease it. Al together, our results showed that botrocetin present in crude venom does not affect thrombocytopenia induced by envenomation, but it changes the levels and function of plasma vWF. SVMP had a marked effect in ADAMTS13, the physiological enzyme that regulates vWF biological activity, which may affect vWF levels indirectly. In addition, thrombocytopenia during B. jararaca envenomation is independent of vWF, and considering the multifactorial features of platelet consumption during envenomation, we suggest that other mechanisms might account for BjV-induced thrombocytopenia. Therefore, we conclude that vWF consumption during B. jararaca envenomation is an ancillary mechanism, but not the main one to decrease platelet counts

Introdução: As modificações evolutivas e o impacto clínico da composição da aterosclerose coronária em pacientes sob prevenção secundária permanecem pouco conhecidos. O ultrassom intravascular com histologia virtual (VH-IVUS) permite caracterizar in vivo tais componentes. Os objetivos desse estudo foram avaliar o papel prognóstico da composição da aterosclerose da árvore coronária proximal, bem como descrever o comportamento dinâmico da placa, explorando a relação entre seus componentes e as alterações geométricas do vaso. Métodos: Conduziu-se um estudo prospectivo, observacional e unicêntrico, que incluiu pacientes encaminhados para intervenção coronária percutânea. Durante essa intervenção, realizou-se VH-IVUS tipo \"artéria inteira\" das três coronárias principais para mensurar os parâmetros geométricos do vaso (luz, membrana elástica externa, placa+média e volume percentual do ateroma) e os componentes das placas (fibrótico, fibrolipídico, núcleo necrótico e cálcio denso). Calculou-se o volume indexado de cada parâmetro por paciente, artéria e subsegmento arterial. Avaliou-se a influência dos volumes indexados da árvore coronária proximal (por paciente), sem considerar a categorização fenotípica das placas, na ocorrência de eventos cardíacos adversos maiores (MACE), definidos como óbito, infarto agudo do miocárdio e revascularização miocárdica não planejada, após 4 anos de seguimento. Em um subgrupo de pacientes, VH-IVUS volumétrico seriado foi realizado para estudar variações do ateroma nas artérias e em seus subsegmentos, testando correlações entre componentes da placa e variações geométricas do vaso. Resultados: Foram incluídos 67 pacientes com idade média de 58,9 ± 9,2 anos, 66% do sexo masculino, 42% diabéticos, 69% multiarteriais e 45% com síndrome coronária aguda recente. Obtiveram-se imagens de VH-IVUS para 255 artérias. As médias dos volumes indexados basais da árvore coronária proximal, em escala de cinza, foram: luz 8,8±2,5mm3/mm, membrana elástica externa 15,4±3,5mm3/mm e placa+média 6,6±2,0mm3/mm, com percentual de volume do ateroma de 42,8±8,9%. Quanto aos componentes do ateroma, predominou o fibrótico 2,1 ± 1,0mm3/mm (61,8 ± 6,6%), seguido por núcleo necrótico 0,6±0,4mm3/mm (16,6±6,7%), fibrolipídico 0,5±0,3mm3/mm (14,1±6,0%) e cálcio denso 0,3±0,2mm3/mm (7,6 ± 4,6%). Após 4,9 anos (intervalo interquartil: 4,5 - 5,1 anos) sob prevenção secundária, ocorreram MACE em 18 pacientes, a maioria por reestenose. Não houve correlação entre os volumes indexados basais da árvore coronária proximal e a ocorrência de MACE. VH-IVUS seriado, após 20,6 meses (intervalo interquartil: 9,1 - 23,8 meses), foi realizado em 52 pacientes. Nas artérias desses pacientes, houve redução no volume indexado de luz, redução no volume indexado de membrana elástica externa, sem alteração no volume indexado de placa+média ou no percentual de volume do ateroma. Modificações na composição da placa foram observadas, com incremento absoluto e relativo dos componentes cálcio denso (0,09±0,21mm3/mm p < 0,01; 2,2±7,1% p < 0,01) e núcleo necrótico (0,13±0,47mm3/mm p < 0,01; 3,0 ± 10,9% p < 0,01), redução relativa do componente fibrolipídico (-0,05 ± 0,81mm3/mm p=0,37; -3,7 ± 10,3% p < 0,01) sem variação do componente fibrótico (-0,04 ± 1,00mm3/mm p=0,62; -1,6 ± 13,3% p=0,12). Nos subsegmentos arteriais, a composição basal da placa correlacionou-se com a resposta de remodelamento do vaso. A quantidade total de volume indexado basal dos componentes não calcificados correlacionou-se positivamente com a resposta de remodelamento constrictiva do vaso, que ocorreu menos frequentemente em diabéticos e associou-se a maior incremento do componente cálcio denso durante a evolução. Conclusão: Em coronarianos sob prevenção secundária, a composição média da aterosclerose na árvore coronariana proximal não se associou a ocorrência de eventos cardíacos adversos maiores. O comportamento dinâmico do ateroma foi compatível com estabilização da doença, ocorrendo variação não significativa na quantidade de placa, redução luminal associada a remodelamento negativo do vaso e modificação nos constituintes da placa com desvio de um \"perfil fibrolipídico para um mais calcificado\". A quantidade basal de componentes não calcificados da placa modulou as alterações geométricas direcionadas para o remodelamento constrictivo do vaso / Background: Clinical impact of coronary atherosclerosis composition and their modifications related to secondary prevention remains not well known. Virtual histology intravascular ultrasound (VH-IVUS) allows in vivo characterization of atherosclerotic plaque components. The aim of this study was to evaluate the prognostic value of atherosclerotic plaque composition of proximal coronary tree and to describe the variations in atherosclerotic plaques, exploring the relations of theirs components with geometric modifications of the vessel. Methods: It was conducted a prospective observational single center study, including patients referred to percutaneous coronary intervention. During the interventional procedure, volumetric three vessel \"whole artery\" VH-IVUS was performed to measure geometric vessel (lumen, elastic external membrane, plaque+media, percent atheroma volume) and atheroma compositional parameters (fibrotic, fibrolipid, necrotic core, and dense calcium). It was computed the volumetric index of each parameter in patient, artery, and arterial subsegment level. It was tested the prediction value of the volumetric indexes of proximal coronary tree (patient level), disregarding the phenotypical categorization of plaques, in the occurrence of major adverse cardiac events (MACE) defined by death, acute myocardial infarction, and unplanned myocardial revascularization, after 4 years of follow-up. In a subgroup of patients, serial volumetric VH-IVUS was performed to evaluate the modifications of the atheroma in arteries and their subsegments, testing the correlations between plaque components and geometric variations of the vessel. Results: It was included 67 patients with mean age of 58.9 ± 9.2 yearsold, 66% male, 42% with diabetes, 69% with multivessel coronary disease, and 45% with recent acute coronary syndrome. VH-IVUS was obtained for 255 arteries. The average of volumetric indexes of proximal coronary tree was: lumen 8.8±2.5mm3/mm; elastic external membrane 15.4 ± 3.5mm3/mm; placa+media 6.6 ± 2.0mm3/mm and percent atheroma volume 42.8±8.9%. In terms of composition, the predominant component was fibrotic 2.1 ± 1,0mm3/mm (61.8 ± 6.6%), followed by necrotic core 0.6 ± 0.4mm3/mm (16.6 ± 6.7%), fibrolipid 0.5 ± 0.3mm3/mm (14.1 ± 6.0%) and dense calcium 0.3 ± 0.2mm3/mm (7.6 ± 4.6%). After a 4.9- year (interquartile interval: 4.5 - 5.1) follow-up, MACE occurred in 18 patients, mainly motivated by stent reestenosis. There was no correlation between baseline volumetric indexes of proximal coronary tree and the occurrence of MACE. Serial VH-IVUS, after 20.6 months (interquartile interval: 9.1 - 23.8 months), was performed in 52 patients. In arterial level, there was decrease in lumen index volume, reduction in elastic external membrane index volume, with no variation in placa+media index volume and percent atheroma volume. Changes in plaque composition were observed, with increase in absolute and relative dense calcium (0.09 ± 0.21mm3/mm p < 0.01; 2.2 ± 7.1% p < 0.01) and necrotic core (0.13 ± 0.47mm3/mm p < 0.01; 3.0 ± 10.9% p < 0.01), relative decrease in fibrolipid (-0.05 ± 0.81mm3/mm p=0.37; - 3.7 ± 10.3% p < 0.01), and no modification in fibrotic component (-0.04 ± 1.00mm3/mm p=0.62; -1.6 ± 13.3% p=0.12). In arterial subsegment level, baseline plaque composition correlated with remodeling response of the vessel. Total index volume of non-calcified plaque components positively correlated with a trend toward constrictive remodeling of the vessel, which occurred less frequently in diabetic patients and was associated with greater increase in dense calcium component. Conclusion: In patients with coronary artery disease treated with secondary prevention strategies, mean atherosclerotic plaque composition of the proximal coronary tree was not able to predict major adverse cardiac events. Dynamic behavior of atheroma in these patients was compatible with disease stabilization, related to quantitative plaque steadiness, lumen reduction associated with constrictive remodeling of the vessel, and modifications of plaque components with shifting from \"fibrolipid to more calcified profile\". Total non-calcified plaque components modulated geometric modifications toward constrictive remodeling of the vessel

Fundamentos: O implante de stents coronários constitui-se na técnica mais prevalente de revascularização percutânea, em especial pela prevenção da reestenose, quando comparado às intervenções com o balão. No entanto, a reestenose intra-stent, que ocorre em cerca de 25% dos casos, restringe os seus benefícios clínicos e econômicos tardios. Demonstrou-se que a hiperplasia neo-intimal decorrente da reação da parede vascular causada pelo implante do stent, é responsável pelas recidivas. Interroga-se se um protocolo de medicamentos contemplando doses máximas de manutenção de clopidogrel e atorvastatina poderia reduzir a hiperplasia neo-intimal e a reestenose. Objetivos: O objetivo primário foi aferir se esta associação de medicamentos reduziria o volume de hiperplasia neo-intimal (35% ou mais), expressa pela obstrução volumétrica da luz, mensurada pelo ultrassom intracoronário, 12 meses após a intervenção. Os objetivos secundários foram: os resultados da angiografia quantitativa e os eventos cardíacos adversos maiores (óbito, infarto e revascularização do vaso-alvo). Casuística e métodos: Foram incluídos casos eletivos e com lesões primárias nas artérias naturais. Os pacientes foram tratados com stents não farmacológicos e randomizados em dois grupos: A, com 50 pacientes medicados com doses máximas de clopidogrel e atorvastatina; e grupo B com 50 casos, medicados com 75mg de clopidogrel e doses de sinvastatina rotineiramente prescritas para obtenção das metas recomendadas para controle lipídico. Resultados: Ambos os grupos não apresentaram diferenças significantes em relação às características clínicas, angiográficas e técnicas, com exceção do diabetes, mais comum em A (36% vs 16%; p=0,02). Aos 12 meses de evolução, observaram-se eventos cardíacos maiores (12% versus 18%; p = 0,56) e revascularização do vaso-alvo (4% versus 2%; p>0,99) sem diferença significante. Nova angiografia coronária foi obtida em 98% dos casos dos dois grupos, observando-se taxa de reestenose de 8,1% e 8,2% nos grupos A e B (p>0,99). A perda tardia da luz arterial foi semelhante [0,9 mm (DP 0,5 mm) versus 1,1 mm (DP 0,7 mm); p = 0,22], o mesmo acontecendo com o diâmetro mínimo da luz [2,2 mm (DP 0,6 mm) versus 1,9 mm (DP 0,6 mm); p = 0,12]. Realizou-se ultrassom intracoronário em 98% dos pacientes de ambos os grupos, observando-se obstrução do volume da luz de 36,3% (DP 10,3%) no grupo A e de 40,1% (DP 10,9%) no grupo B (p = 0,14). Conclusões: Os resultados deste estudo demonstram que: 1) a terapêutica adjunta utilizando doses máximas de clopidogrel 150 mg/dia e atorvastatina 80 mg/dia não reduz o volume de hiperplasia neo-intimal, expressa pela obstrução volumétrica da luz; 2) as variáveis da angiografia quantitativa e os eventos cardíacos adversos maiores não mostraram diferenças significativas entre os dois grupos. / Coronary stent implantation is the current technique of choice in patients undergoing percutaneous intervention. They effectively reduce acute occlusion and restenosis even in complex lesions. However, instent restenosis occurs in up to 25% of the treated cases and there are several theories elaborating the possible relation between coronary artery thrombosis and inflammation to neointimal proliferation and the mechanism of obstruction recurrence. There are questions whether an optimized medical treatment based on maximum doses of Clopidogrel and Atorvastatin could limit neointimal hyperplasia and restenosis. Objectives: Primary endpoint was to assess the efficacy of this scheme in reducing neointimal hyperplasia volume (XX% or more), according to intravascular ultrasound measurements, 12 months after the index intervention. Secondary endpoints were quantitative angiography measurements and major adverse cardiac events (death, myocardial infarction and target vessel revascularization). Methods: We included patients with de novo lesions undergoing elective implantation of uncoated stents. Patients were divided according to the drug regimen into Group A - 50 patients receiving maximal atorvastatin and clopidogrel doses; and Group B - 50 cases treated with standard clopidogrel and simvastatin doses. Results: Groups were similar concerning clinical and angiographic characteristics, except for diabetes, more frequent in Group A (36% vs 16%, p = 0.02). At the end of 12 months major cardiac events (12% versus 18%, p = 0.56) and target vessel revascularization (4% versus 2%, p> 0.99) did not show differences between groups. Coronary angiography was obtained in 98% of the cases and the restenosis rate was 8.1% (A group) and 8,2% (B group) (p> 0.99). Late luminal loss was similar [0.9 mm (SD 0.5 mm) versus 1.1 mm (SD 0.7 mm), p = 0.22], as well as the minimum lumen diameter [2.2 mm (SD 0.6 mm) versus 1.9 mm (SD 0.6 mm), p = 0.12]. IVUS was done in 98% of patients in both groups, and the volume of neointimal hyperplasia was not significantly different in both groups [61.8 mm 3 (SD 35.4 mm3) mm3 versus 66.3 (SD 31.6 mm3), p = 0.58]. Luminal volume obstruction was 36.3% (SD 10.3%) in group A and 40.1% (SD 10.9%) in group B (p = 0.14). Conclusions: According to our results we may conclude that: 1) the therapeutic regimen using maximum doses of atorvastatin and clopidogrel did not reduce the volume of neointimal hyperplasia, 2) restenosis rate, quantitative angiography results and the rate of major adverse cardiac events were not affected by the treatment regimen.